Showing 20 of 206 recruiting trials for “t-cell-prolymphocytic-leukemia”
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
👨⚕️ Study Director, Dizal (Jiangsu) Pharmaceutical Co., Ltd.📍 2 sites📅 Started Sep 2025View details ↗
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
👨⚕️ Wang Sanbin, MD, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jul 2025View details ↗
A Phase I Dose Finding Study of MB-CART2219.1
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
RecruitingNCT07326930 ↗
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
👨⚕️ Mazyar Shadman, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Jun 2025View details ↗
Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
👨⚕️ Vironexis Clinical Trials, Vironexis Biotherapeutics Inc.📍 9 sites📅 Started May 2025View details ↗
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →